Showing results (2151-2160 of 3,641) with videos related to
Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|October 16, 2024
The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-early breast cancer: A comprehensive updated meta-analysis of randomized clinical trialsMerve Keskinkilic, Mehmet Emin Arayici, Yasemin Basbinar, et al.Breast (Edinburgh, Scotland)|October 15, 2024
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4-6 inhibitors?Ilkay Gültürk, Rumeysa Colak, Caner Kapar, et al.Breast (Edinburgh, Scotland)|September 26, 2024
The impact of advanced oncoplastic surgery on breast-conserving surgery rates: A retrospective cohort study of 3,875 breast cancer procedures at a tertiary referral centreAngus Reid, Robert Thomas, Andrew Pieri, et al.Breast (Edinburgh, Scotland)|September 25, 2024
AI-based strategies in breast mass ≤ 2 cm classification with mammography and tomosynthesisZhenzhen Shao, Yuxin Cai, Yujuan Hao, et al.Breast (Edinburgh, Scotland)|October 2, 2024
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancerShuqin Dai, Xingping Wu, Xuefang Huang, et al.Breast (Edinburgh, Scotland)|September 13, 2024
Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysisJannah Baker, Naomi Noguchi, M Luke Marinovich, et al.Breast (Edinburgh, Scotland)|September 20, 2024
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.Breast (Edinburgh, Scotland)|October 17, 2024
Multimodal ultrasound assessment of mass and non-mass enhancements by MRI: Diagnostic accuracy in idiopathic granulomatous mastitis and breast cancerLiang Yin, Xi Wei, Qing Zhang, et al.Breast (Edinburgh, Scotland)|November 7, 2024
Adjuvant denosumab for early breast cancer-Evidence and controversyLaura Moretti, Laura Richelmi, Deborah Cosentini, et al.Breast (Edinburgh, Scotland)|October 23, 2024
Radiotherapy and increased risk of second primary cancers in breast cancer survivors: An epidemiological and large cohort studyNiuniu Hou, Zhe Wang, Yuwei Ling, et al.Pageof 365